Todays Report: Today: 109 Shares of Roche Holding Ltd. (RHHBY) are sold by GRATRY & Co LLC

Today: 109 Shares of Roche Holding Ltd. (RHHBY) are sold by GRATRY & Co LLC

GRATRY & Co LLC lowered its position in shares of Roche Holding Ltd. (NASDAQ:RHHBY) by 0.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,125 shares of the company’s stock after selling 109 shares during the period. GRATRY & Co LLC’s holdings in Roche Holding were worth $406,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of RHHBY. Abner Herrman & Brock LLC raised its position in shares of Roche Holding by 32.7% in the third quarter. Abner Herrman & Brock LLC now owns 10,841 shares of the company’s stock valued at $337,000 after buying an additional 2,673 shares during the last quarter. Quadrant Capital Group LLC raised its position in shares of Roche Holding by 12.6% in the third quarter. Quadrant Capital Group LLC now owns 11,689 shares of the company’s stock valued at $354,000 after buying an additional 1,312 shares during the last quarter. Eqis Capital Management Inc. raised its position in shares of Roche Holding by 4.1% in the third quarter. Eqis Capital Management Inc. now owns 11,650 shares of the company’s stock valued at $361,000 after buying an additional 464 shares during the last quarter. New England Research & Management Inc. acquired a new position in shares of Roche Holding during the third quarter valued at approximately $503,000. Finally, Genesee Valley Trust Co. raised its position in shares of Roche Holding by 1.6% in the third quarter. Genesee Valley Trust Co. now owns 16,891 shares of the company’s stock valued at $525,000 after buying an additional 271 shares during the last quarter.

Shares of Roche Holding Ltd. (NASDAQ:RHHBY) opened at 28.02 on Monday. The company has a 50-day moving average price of $29.05 and a 200-day moving average price of $31.02. Roche Holding Ltd. has a 52-week low of $27.06 and a 52-week high of $35.13. The company has a market cap of $191.02 billion and a P/E ratio of 21.14.

RHHBY has been the subject of several recent analyst reports. Zacks Investment Research lowered Roche Holding from a “hold” rating to a “strong sell” rating in a report on Monday, October 17th. Citigroup Inc. restated a “buy” rating on shares of Roche Holding in a research report on Wednesday, August 3rd.

About Roche Holding

Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai.

Related posts

Leave a Comment